RxDoctor Payments Data

Kimberly Chou, MD

Geriatric Medicine · Austin, TXNPI 1255789962

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 59 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 19 manufacturers reported payments, led by AbbVie at 28.3% of the total. Reporting peaked in 2023 at $454 and has fallen 76.5% since, to $107 in 2025.

$1,391in general payments, 2019–2025

Across 59 payments — averaging $23.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$394
  • Organogenesis Inc.$249
  • Kerecis Limited$222
  • Neurocrine Biosciences, Inc.$85
  • KCI USA, Inc.$70
  • Convatec Inc.$63
  • plus $308 from 13 others

What the payments were for

  • Food & beverage$1,391100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,391 in reported general payments places this provider in the 80th percentile of 275 geriatric medicine providers in Texas.

See all geriatric medicine providers in Texas

Medicare billing

Part B allowed, 2024
$149,878
Medicare patients
283
Services billed
2,053

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban23$5,018
Oxycodone Hcl75$1,035
Gabapentin43$888
Lacosamide14$752
Atorvastatin Calcium45$721
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen36$663
Albuterol Sulfate HfaAlbuterol Sulfate11$628
Pantoprazole Sodium20$307
Mirtazapine13$300
Levothyroxine Sodium27$296
Pregabalin14$281
Cephalexin11$272
Potassium Chloride14$269
Donepezil Hcl21$256
CeftriaxoneCeftriaxone Sodium13$253

Paid to pharmacies, not to this prescriber.

Other geriatric medicine in Austin

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →